ERBB2 and breast cancer: We hypothesize that GLUT1 is a critical mediator of cell survival, proliferation, glucose uptake and aerobic glycolysis in breast cancer cells in vitro and in mammary tumors in vivo, and tested this hypothesis using ErbB2 or PyVMT overexpressing mouse mammary carcinoma cell lines and tumors.